Severe acute exacerbation of liver disease may reduce or delay emergence of YMDD motif mutants in long‐term lamivudine therapy for hepatitis B e antigen‐positive chronic hepatitis B
暂无分享,去创建一个
Yoshiyuki Suzuki | A. Tsubota | M. Kobayashi | K. Ikeda | H. Kumada | Y. Arase | T. Hosaka | F. Suzuki | H. Sezaki | N. Akuta | S. Saitoh | T. Someya | J. Sato | M. Matsuda | M. Kobayashi